Thomson Medical GroupFRA:3H5 Median PS Value is €0.07 as of Jun. 30, 2026, which is 100% below its 10-year median of 0.43. The stock has 6 warning signs investors should review. Among 262 Healthcare Providers & Services companies, Thomson Medical Group ranks better than 67.18% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Thomson Medical Group's Median PS Value or its related term are showing as below:
FRA:3H5'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.43 Med: 0.43 Max: 0.5
Current: 0.5
During the past 13 years, the highest Price to Median PS Value of Thomson Medical Group was 0.50. The lowest was 0.43. And the median was 0.43.
FRA:3H5's Price-to-Median-PS-Value is ranked better than 67.18% of 262
companies
in the Healthcare Providers & Services industry
Industry Median: 0.7
vs FRA:3H5: 0.50
Thomson Medical Group (FRA:3H5) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Thomson Medical Group's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.035
/
0.07
=
0.50
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thomson Medical Group Median PS Value Related Terms
Thomson Medical Group Median PS Value Historical Data
* Premium members only.
The historical data trend for Thomson Medical Group's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:3H5 vs HCA, THC, DVA: Median PS Value Comparison
For the Medical Care Facilities subindustry, Thomson Medical Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thomson Medical Group Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Thomson Medical Group's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Thomson Medical Group's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 7.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Thomson Medical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thomson Medical Group (FRA:3H5) has a Median PS Value of €0.07 as of Jun. 30, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Thomson Medical Group and its competitors. This is 84% below median its historical median of 0.43. Over the past decade, Thomson Medical Group's Median PS Value has ranged from 0.43 to 0.50. According to the industry distribution chart, Thomson Medical Group ranks #86 out of 262 companies in the Healthcare Providers & Services industry, placing it in the top 32.8%.
Is Thomson Medical Group's Median PS Value too high?
Thomson Medical Group's current Median PS Value of €0.07 is 84% below median its 10-year median of 0.43. Over the past 10 years, this metric has ranged from a low of 0.43 to a high of 0.50. Based on the distribution chart, Thomson Medical Group ranks #86 out of 262 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Thomson Medical Group's Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Thomson Medical Group ranks #86 out of 262 companies for Median PS Value. This puts Thomson Medical Group in the upper half of its industry. The industry median Median PS Value is 0.70. Historically, Thomson Medical Group's own Median PS Value has ranged from 0.43 to 0.50 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.70, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Thomson Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thomson Medical Group's current Median PS Value is €0.07, which is 84% below median its own 10-year median of 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thomson Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Thomson Medical Group (FRA:3H5) is currently considered Possible Value Trap. The stock's GF Value™ is €0.05, compared to a current price of €0.04 — trading 30% below its estimated fair value. The current Median PS Value is €0.07, which is 84% below median its 10-year median of 0.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Thomson Medical Group (FRA:3H5), the current Median PS Value is €0.07 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3H5 has been successfully added to your 